Addition of Lou Milione and Dr. Charles Schumacher to board of advisors

Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) registrant, is pleased to announce the addition of Charles S. Schumacher, M.D, an orthopaedic surgeon at Covington Orthopedic Sports Medicine Institute, and Louis J. Milione, Senior Managing Director with Guidepost Solutions’ Monitoring, Compliance and Investigations practice to its Board of Advisors. Read more →

Previous
Previous

BRC praises DOJ and DEA’s statement to move cannabis production for research forward

Next
Next

BRC encourages congress to take up cannabis legislation